News | May 24, 2024
Swixx Biopharma acquires Biopas to expand in Latin America
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The facility will manufacture tablets, capsules, and injections for the oncology segment
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
10+ emerging markets, Japan & ANZ transition in final phase
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Subscribe To Our Newsletter & Stay Updated
